Slide 1: 2Q 2023 Earnings Commentary: Summary
2Q 2023 Earnings Commentary Revenue Adjusted Expense* Adjusted Diluted EPS 2Q 2023 Summary in millions CME Group continued to work closely with customers and execute on $1,500 $2.50 strategic initiatives alongside a positive macroeconomic backdrop for risk management opportunities that drove strong
Slide 2: 2Q 2023 Highlights & Commentary
2Q 2023 Earnings Commentary - Unaudited 2Q 2023 Highlights & Commentary (ADV and open interest (OI) stated in contracts, except for cash markets) CME Group’s consistent strategic execution drove double-digit earnings growth for the 8th consecutive quarter in 2Q 2023 Adjusted Financials* CME Group Ad
Slide 3: Commodities Products and Options growth were standouts in 2Q23
2Q 2023 Earnings Commentary - Unaudited Commodities Products and Options growth were standouts in 2Q23 Agricultural Products ADV up 34% to 1.8M, the second-highest quarterly ADV on record Agricultural Products ADV • Corn F/O ADV of 598K, up 22% in millions • Record Agricultural Products options ADV
Slide 4: Interest Rates ADV grew 6% YoY in 2Q
2Q 2023 Earnings Commentary - Unaudited Interest Rates ADV grew 6% YoY in 2Q, and is on record pace with 1H23 up 11% versus 1H22 Interest Rates ADV CME Group Interest Rate Futures in millions Aggregate Number of Large Open Interest Holders Source: CFTC 15 3,300 12.9 11.6 2,800 10 +3% 2,300 5 +21% 1,
Slide 5: 2Q 2023 Product Detail - New product offerings
2Q 2023 Earnings Commentary - Unaudited CME Group announced several new product offerings in 2Q, and recent product launches are building • Announced Monday/Wednesday expiries for WTI Crude Oil weekly options targeted for July 31, building upon the record activity seen recently in the Friday expiry,
Slide 6: Financial Results
2Q 2023 Earnings Commentary - Unaudited Financial Results Dividends Declared $ in millions • 2Q23 revenue was $1.4 billion. 2Q23 clearing and $2,800 transaction fees revenue totaled $1.1 billion Annual Variable including approximately $70 million of transaction Dividend revenue generated from cash m
Slide 7: Appendix: Micro Product Quarterly Details
2Q 2023 Earnings Commentary - Unaudited Financial Results Appendix Micro Product Quarterly Details ADV in thousands / RPC in cents except for Micro Crypto Micro Equity Index Products (including Micro Crypto) 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 ADV 1,891 1,858 2,286 3,437 3,319 3,025 2,963 2
Slide 8: Use of Non-GAAP Measures; Forward-Looking Statements
2Q 2023 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate